LFMD LifeMD Inc
Company Analysis
Latest News
🟢 LifeMD is trading 5.5% up in pre-market; reason remains uncertain
LifeMD is trading at $2.29, up 5.53% in pre-market; no clear company-specific news explains the rise. - On October 20, LifeMD announced it will report...
🔴 LifeMD is trading 5% down as the decline’s cause remains unclear
LifeMD is trading at $2.13, down 5.12%, with the cause of the October 21 decline unclear. - The available news search surfaced no clear company-specific...
🟢 LifeMD is trading 6% up in pre-market
LifeMD is trading at $2.38, up 6.01% in pre-market, with no clear company-specific catalyst identified. - LifeMD announced after the October 20 close that it...
🔴 LifeMD is trading 5% down today amid oil-price and Treasury-yield concerns
LifeMD is trading 5.02% down at $2.65 on October 8, 2026; broader market pressure is the likeliest context, though no direct cause is established. - Search...
🟢 LifeMD is trading 9.5% up in pre-market with no confirmed company-specific catalyst
LifeMD is trading 9.5% up in pre-market at $3.00 on October 5, 2026, versus its October 2 close of $2.74, with no confirmed company-specific announcement...
🟢 LifeMD is trading 8% up in pre-market with no confirmed company-specific catalyst
LifeMD is trading at $3.08, up 8.21%, amid broad-market sentiment; no company-specific catalyst explaining the October 2 pre-market move surfaced. - U.S....
🟢 LifeMD is trading 8.2% up in after-hours trading with no clear company-specific catalyst identified
LifeMD is trading at $3.30, up 8.20% after-hours on September 23, 2026, with no clear company-specific announcement identified. - LifeMD closed the regular...
🔴 LifeMD is trading 5% down today as crude and Treasury yields rise
LifeMD is trading at $3.13, with a -5.00% change, alongside a weaker market as the S&P 500, Nasdaq Composite, and Dow Jones are all lower. - No clear...
🔴 LifeMD is trading 5.3% down today as catalyst remains uncertain
LifeMD is trading 5.3% down at $3.22, with no clear company-specific catalyst identified for the September 16, 2026 decline. - The September 15 AT&T...
LifeMD Announces Exclusive Strategic Collaboration with AT&T
LifeMD, Inc. has entered into an exclusive strategic collaboration with AT&T Services, Inc. to provide complimentary LifeMD memberships to eligible AT&T...
🟢 LifeMD is trading 10.16% up today with no clear catalyst identified
LifeMD is trading 10.16% up now at $3.36, with no clear company-specific catalyst identified. - No company-specific announcement, filing, earnings update, or...
🟢 LifeMD is trading 6.72% up today
LifeMD is trading 6.72% up at $3.25, with no clear company-specific announcement, filing, earnings update, or analyst action dated September 14, 2026...
🔴 LifeMD is trading 5% down today as insurance concerns deepen
LifeMD is trading 5% down at $2.94, primarily amid healthcare-sector pressure as insurance concerns deepen. - The stock fell from the September 8 close of...
🟢 LifeMD is trading 10% up in pre-market with no clear catalyst identified
LifeMD is trading at $3.39, up 10.06%, with no reliable company-specific catalyst identified for September 8, 2026. - LifeMD’s latest major update was its...
🟢 LifeMD is trading 6.71% up in pre-market amid stronger technology and growth-stock sentiment
LifeMD is trading at $3.50 (+6.71%), broadly aligned with stronger pre-market technology and growth-stock sentiment. - No new company-specific announcement or...
🟢 LifeMD is trading 5.72% up in after-hours trading — catalyst remains unconfirmed
LifeMD is trading 5.72% up at $3.51 in after-hours trading after its $3.32 close on August 17, 2026; catalyst unconfirmed. - Latest August 5 earnings: $47.3...
🟢 LifeMD is trading 8.2% up in after-hours trading with no clear catalyst identified
LifeMD is trading 8.2% up at $3.73 after rising from the August 14 regular-session close of $3.45, with no clear catalyst identified. - No credible August 14...
🔴 LifeMD is trading 5% down today after Q2 revenue miss and reduced 2026 guidance
LifeMD is trading 5% down at $3.44 after its Q2 revenue miss and reduced 2026 guidance. - The August 5, 2026, report showed revenue of $47.3 million, below...
🔴 LifeMD is trading 5.8% down in pre-market after Q2 revenue miss and lower 2026 guidance
LifeMD is trading 5.8% down in pre-market at $3.41 as investors continued reacting to its August 5, 2026, second-quarter results, including a revenue miss and...
LifeMD Drops 7% as Traders Cash Out Before Earnings — But Did the Real Bad News Already Land?
Shares of LifeMD slid 7.2% to $3.62 on August 7, extending a sell-off that began after the telehealth company released Q2 2026 results two days ago. While the...